🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hungry, hungry immune cells can be programmed to fight cancer! CSHL Prof Mikala Egeblad and her lab developed a treatment that reprograms immune cells to consume breast cancer cells.

Today in Cancer Cell our study on reprogramming the immune microenvironment to limit metastasis cell.com/cancer-cell/fu…. It started >a decade ago, when Tim Kees, my 1st postdoc, convinced me to start a new project with movies showing macrophages killing cancer cells.

Online Now: Activating a collaborative innate-adaptive immune response to control metastasis dlvr.it/S6tDp8

Our paper on reprogramming the TME to reduce metastasis is now out in print Cancer Cell (cell.com/cancer-cell/fu…). Beautiful cover art by @netjuanma.

Redirecting tumor macrophage activity to fight cancer: Make room for the next era of anti-cancer drugs dlvr.it/S9pT7R

What makes a welcoming home for a wandering cancer cell? CSHL Professor Mikala Egeblad (Mikala Egeblad) answers this by examining a tumor’s surrounding “neighborhood”. cshl.edu/fighting-cance…

I am excited for our new translational direction at Johns Hopkins Medicine Dept. of Cell Bio, Johns Hopkins Kimmel Cancer Center, Convergence Institute, and the brand new tedgiovanis Institute. 🙏to the Egeblad lab members moving with me. We are recruiting : ✍️ [email protected] to learn more.

I am delighted to announce that I will soon join The Crick Institute in London! My lab will study how cancer affects the host "macroenvironment", especially the hematopoietic, cardiovascular, and immune systems. Sounds interesting? Join us! crick.ac.uk/research/labs/…

It is such an honor to receive the Fidler innovation award from the MRS. The work the society is doing to engage early stage career scientists, involve patient advocates, and drive progress towards preventing and treating metastasis is very inspiring. Thank you very much!

Insights: Lijuan Sun and Mikala Egeblad Cold Spring Harbor Laboratory discuss new work from Ian W. Folkert, MD, PhD, William Anthony Molina et al. Haldar Lab @ Penn (hubs.la/Q02Rwt8B0) that defines an “iron-rich” subset of tumor-associated #macrophages (iTAMs). hubs.la/Q02Rwg4L0

Jiang Lab @ Moffitt Cancer Center is recruiting! We are looking for a Postdoc interested in redox control of cancer cells! …cancer-center-careers.hctsportals.com/jobs/1740466-c…

Honored to have attended the AACR Translational Cancer Research for Basic Scientists Workshop. An invaluable experience. Thank you, Dr. George Demetri, Dr. Ryan Corcoran, and Dr. Elaine Mardis for organizing this outstanding event! Excited to have met such remarkable scientists!

#AACRtumorenviron24 cochairs Ilaria Malanchi, Mikala Egeblad, and Sergei Grivennikov welcome attendees to the AACR conference on Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer tonight in Boston. Mikala Egeblad Sergei Grivennikov ilaria Malanchi

Poster presenters shared their work with attendees Tuesday evening during the AACR Special Conference on Tumor-body Interactions. The meeting continues through Wednesday in Boston. #AACRtumorenviron24 #AACRTME

Fantastic meeting and exciting discussions at #AACRtumorenviron24. Thank you so much to the organizers Sergei Grivennikov ilaria Malanchi Neta Erez- ErezLab🎗️ Mikala Egeblad -my wonderful mentor.

So great to meet my friends Xue-Yan He 何雪妍 Xiao Han 韩笑 Nan Zhang Xueqian Zhuang

AACR members have elected five members of the AACR Board of Directors for the 2025-2028 term. Congratulations to Johann S. de Bono, MD, PhD, Mikala Egeblad, PhD, Crystal L. Mackall, MD, FAACR, Charles W.M. Roberts, MD, PhD, and Timothy A. Yap, MBBS, PhD. brnw.ch/21wRARe